Utilization patterns and medication adherence in patients with type 2 diabetes: Variations based on type of pharmacy (chain vs independent)

Research in Social and Administrative Pharmacy

Volumn 3, Issue 4, 2007, Pages 378-391

  Kalsekar, Iftekhar ^a   Sheehan, Courtney ^b   Peak, Amy ^a  

^a BUTLER UNIVERSITY   (United States)

^b Terre Haute Regional Hospital   (United States)

Author keywords

Adherence; Administrative claims data; Chain pharmacies; Independent pharmacies; Medicaid; Oral hypoglycemic agents; Type 2 diabetes mellitus

Indexed keywords

ANTIDIABETIC AGENT;

ADULT; AGE; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; DRUG MONITORING; DRUG UTILIZATION; FEMALE; HUMAN; MALE; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORGANIZATION AND MANAGEMENT; PATIENT COMPLIANCE; PHARMACY; POPULATION; PRESCRIPTION; RETROSPECTIVE STUDY; STATISTICAL MODEL; TREATMENT OUTCOME;

ADULT; AGE FACTORS; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DRUG MONITORING; DRUG UTILIZATION; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; LOGISTIC MODELS; MALE; PATIENT COMPLIANCE; PHARMACIES; POPULATION; PRESCRIPTIONS, DRUG; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 36849057066     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2006.11.002     Document Type: Article

References (36)

1. American Diabetes Association. Available at:. http://www.diabetes.org/diabetes-statistics/national-diabetes-fact-sheet.jsp Accessed 29.11.2005
2. UKPDS Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type-2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
3. Diehl A.K., Bauer R.L., and Sugarek N. Correlates of medication compliance in non-insulin dependent diabetes mellitus. South Med J 80 (1987) 332-335
4. Chousa F.P., Guillen V.F.G., Otero M.D., Beltran D.O., Lopez R.P., and Sanchez J.M. Usefulness of six indirect methods to evaluate drug therapy compliance in non-insulin dependent diabetes mellitus. Rev Clin Esp 197 (1997) 555-559
5. Peterson G.M., McLean S., and Senator G.B. Determinants of patient compliance, control, presence of complications, and handicap in non-insulin dependent diabetes. Aust N Z J Med 14 (1984) 135-141
6. Shectman J.M., Nadkarni M.M., and Voss J.D. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care 25 (2002) 1015-1021
7. Howard T, Stang P, Lydick E. Increased morbidity and mortality associated with discontinuation of oral antidiabetic therapies [abstract]. 35th Annual Meeting of the European Association for the study of Diabetes, Brussels, Belgium, 1999.
8. Cramer J.A. A systematic review of adherence with medications for diabetes. Diabetes Care 27 (2004) 1218-1224
9. Paes A.H.P., Bakker A., and Soe-Agnie C.J. Impact of dosage frequency in patient compliance. Diabetes Care 20 (1997) 1512-1517
10. Nagasawa M., Smith M.C., Barnes Jr. J.H., and Fincham J.E. Meta-analysis of correlates of diabetes patients' compliance with prescribed medications. Diabetes Educ 16 (1990) 192-200
11. Haynes R.B. Determinants of compliance: the disease and the mechanics of treatment. In: Haynes R.B., Taylor D.W., and Sackett D.L. (Eds). Compliance in Health Care (1979), John Hopkins University Press, Baltimore 49-62
12. Berringer R., Shibley M.C., Cary C.C., Pugh C.B., Powers P.A., and Rafi J.A. Outcomes of a community pharmacy-based diabetes monitoring program. J Am Pharm Assoc 39 (1999) 791-797
13. Cranor C.W., and Christensen D.B. The Asheville Project: short-term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc 43 (2003) 149-159
14. Bond C.A., and Raehl C.L. Pharmacists' assessment of dispensing errors: risk factors, practice sites, professional functions, and satisfaction. Pharmacotherapy 21 (2001) 614-626
15. Briesacher B., and Corey R. Patient satisfaction with pharmaceutical services at independent and chain pharmacies. Am J Health Syst Pharm 54 (1997) 531-536
16. National Community Pharmacist Association. Independent Pharmacies Take Top Honors In Consumer Reports Nationwide Survey. Available at:. http://www.ncpanet.org/news_press/press_releases/2003/independent_pharmacies_take_top_honors_in_09-10-2003.shtml Accessed 15.11.2005
17. Ware J.E., and Davies A.R. Behavioral consequences of consumer dissatisfaction with medical care. Eval Program Plann 6 (1983) 185-210
18. Zastowny T.R., Roghmann K.J., Cafferata G.L., et al. Patient satisfaction and the use of health services: explorations in causality. Med Care 27 (1989) 705-723
19. Quinn L. Pharmacologic management of the patient with type 2 diabetes. Nurs Clin North Am 36 (2001) 217-242
20. West Virginia Board of Pharmacy Business Search. Available at:. http://www.state.wv.us/pharmacy/index.cfm?fuseaction=Business.fa_searchBusiness Accessed 15.01.2006
21. Steiner J.F., Koepsell T.D., Fihn S.D., and Inui T.S. A general method of compliance assessment using centralized pharmacy records. Description and validation. Med Care 26 (1988) 814-823
22. Kalsekar I., Madhavan S., Amonkar M., et al. Depression in patients with type 2 diabetes: impact on adherence to oral hypoglycemic agents. Ann Pharmacother 40 (2006) 605-611
23. Kalsekar I., Madhavan S., Amonkar M., et al. Impact of depression on utilization patterns of oral hypoglycemic agents in patients newly diagnosed with type 2 diabetes mellitus: a retrospective cohort analysis. Clin Ther 28 (2006) 306-318
24. Bocuzzi S.J., Wogen J., Fox J., Sung J.C., Shah A.B., and Kim J. Utilization of oral hypoglycemic agents in a drug-insured US population. Diabetes Care 24 (2001) 1411-1415
25. Melfi C.A., Chawla A.J., Croghan T.W., Hanna M.P., Kennedy S., and Sredl K. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Arch Gen Psychiatry 55 (1998) 1128-1132
26. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 372-383
27. D'Hoore W., Bouckaert A., and Tilquin C. Practical considerations on the use of the Charlson comorbidity index with administrative databases. J Clin Epidemiol 49 (1996) 1429-1433
28. Spoelstra J.A., Stolk R.P., Heerdink E.R., et al. Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?. Pharmacoepidemiol Drug Saf 12 (2003) 121-127
29. Morningstar B.A., Sketris I.S., Kephart G.C., and Sclar D.A. Trends in oral antihyperglycemic and insulin use in the Nova Scotia senior population (1993-1999). Can J Clin Pharmacol 9 (2002) 123-129
30. Skaer T.L., Sclar D.A., Markowski D.J., and Won J.K.H. Effect of value added utilities on prescription refill compliance and Medicaid health care expenditures-a study of patients with non-insulin dependent diabetes mellitus. J Clin Pharm Ther 18 (1993) 295-299
31. Brown J.B., Nichols G.A., Glauber H.S., and Bakst A. Ten-year follow up of antidiabetic drug use, nonadherence, and mortality in a defined population with type-2 diabetes mellitus. Clin Ther 21 (1999) 1045-1057
32. Donnan P.T., MacDonald T.M., and Morris A.D. Adherence to prescribed oral hypoglycemic medication in a population of patients with type 2 diabetes: a retrospective cohort study. Diabet Med 19 (2002) 279-284
33. Dailey G., Kim M.S., and Lian J.F. Patient compliance and persistence with antihyperglycemic drug regimens: evaluation of a Medicaid patient population with type 2 diabetes mellitus. Clin Ther 23 (2001) 1311-1320
34. Hertz R.P., Unger A.N., and Lustik M.B. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance. Clin Ther 27 (2005) 1064-1073
35. Jones J.K., Garkin L., Lian J.F., Staffa J.A., and Fletcher A.P. Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population. BMJ 311 (1995) 293-295
36. Motheral B.R., and Fairman K.A. The use of claims databases for outcomes research: rationale, challenges, and strategies. Clin Ther 19 (1997) 346-366